The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
•Epithelial ovarian cancer is a constellation of diseases challenging development.•Patient classification systems should incorporate multiple descriptive factors.•New platforms for drug development (e.g. neoadjuvant chemotherapy) are encouraged.•Patient advocate collaborators are vital to meeting the many challenges of enrollment.•Surrogate endpoints (e.g. PFS and response) are viable for accelerated...
To explore and facilitate the multifaceted process of drug development and regulatory approval in ovarian cancer.The Society of Gynecologic Oncology (SGO) recently sought and received input from multiple stakeholders including the National Cancer Institute's (NCI) Clinical Therapy Evaluation Program (CTEP), the Food and Drug Administration (FDA), pharmaceutical industry, and patient advocates. This...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.